Skip to main content

Krispy Kreme Inc

For the period ended Mar 31, 2024. Filed May 9, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 9, 2024

DNUT$3.85-4.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Note

Note 8 —Long-Term Debt

The Company’s long-term debt obligations consists of the following:

March 31, 2024December 31, 2023
2023 Facility — term loan$673,750$682,500
2023 Facility — revolving credit facility207,500155,000
Short-term lines of credit17,00011,000
Less: Debt issuance costs(4,109)(4,371)
Finance lease obligations47,96347,117
Total long-term debt942,104891,246
Less: Current portion of long-term debt(60,326)(54,631)
Long-term debt, less current portion$881,778$836,615

2023 Secured Credit Facility

The Company is party to a credit agreement (the “2023 Facility”) consisting of a $300.0 million senior secured revolving credit facility and a term loan with a principal amount of $700.0 million. The 2023 Facility is secured by a first priority lien on substantially all of the Company’s personal property assets, certain real properties, and all of the Company’s domestic wholly owned subsidiaries. Loans made pursuant to the 2023 Facility may be used for general corporate purposes of the Company (including, but not limited to, financing working capital needs, capital expenditures, acquisitions, other investments, dividends, and stock repurchases) and for any other purpose not prohibited under the related loan documents.

Borrowings under the 2023 Facility are generally subject to an interest rate of adjusted term SOFR plus a credit spread adjustment of 0.10% plus (i)2.25% if the Company’s leverage ratio (as defined in the 2023 Facility) equals or exceeds 4.00 to 1.00, (ii)2.00% if the Company’s leverage ratio is less than 4.00 to 1.00 but greater than or equal to 3.00 to 1.00, or (iii)1.75% if the Company’s leverage ratio is less than 3.00 to 1.00. As of March 31, 2024 and December 31, 2023, the unhedged interest rate was 7.43% and 7.46% under the 2023 Facility, respectively. As of March 31, 2024 and December 31, 2023, $505.0 million out of the $673.8 million term loan balance and $505.0 million out of the $682.5 million term loan balance, respectively, was hedged. The effective interest rate on the term loan was approximately 6.78% and 6.80% for the quarter ended March 31, 2024 and fiscal year ended December 31, 2023, respectively. The Company is required to make equal installments of 1.25% of the aggregate closing date principal amount of the term loan on the last day of each fiscal quarter. All remaining term loan and revolving loan balances are to be due at maturity in March 2028.

Short-Term Lines of Credit

The Company is party totwo agreements with existing lenders providing for short-term, uncommitted lines of credit up to $25.0 million. Borrowings under these short-term lines of credit are payable to the lenders on a revolving basis for tenors up to a maximum of three months and are subject to an interest rate of adjusted term SOFR plus a credit spread adjustment of 0.10% plus a margin of 1.75%.

Note 9 —Share-based Compensation

Restricted Stock Units (“RSUs”) and Performance Stock Units (“PSUs”)

The Company and certain of its subsidiaries issue time-vested RSUs and PSUs under their respective executive ownership plans and long-term incentive plans.

RSU and PSU activity under the Company’s various plans during the periods presented is as follows:

(in thousands, except per share amounts)Non-vested shares outstanding at December 31,2023GrantedVestedForfeitedNon-vested shares outstanding at March 31,2024
KKI
RSUs and PSUs6,785104164886,637
Weighted Average Grant Date Fair Value$14.5413.5214.7515.11$14.51
KK U.K.
RSUs7———7
Weighted Average Grant Date Fair Value$29.80———$29.80
Insomnia Cookies
RSUs47—2—45
Weighted Average Grant Date Fair Value$120.21—74.12—$122.42
KK Australia
RSUs185———185
Weighted Average Grant Date Fair Value$1.57———$1.57
KK Mexico
RSUs20———20
Weighted Average Grant Date Fair Value$30.18———$30.18

The Company recorded total non-cash compensation expense related to RSUs and PSUs under the plans of $6.1 million and $4.7 million for the quarters ended March 31, 2024, and April 2, 2023, respectively, which is included in Selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

The unrecognized compensation cost related to the unvested RSUs and PSUs and the weighted average period over which such cost is expected to be recognized are as follows:

As of March 31, 2024
Unrecognized Compensation CostRecognized Over aWeighted AveragePeriod of
KKI$53,6652.9 years
KK U.K.942.2 years
Insomnia Cookies3,3550.9 years
KK Australia741.3 years
KK Mexico2311.4 years

The estimated fair value of restricted stock is calculated using a market approach (i.e., market multiple is used for the KK U.K. and Insomnia Cookies plans and an agreed-upon EBITDA buyout multiple is used for KK Australia and KK Mexico plans).

Time-Vested Stock Options

KKI issues time-vested stock options under its Omnibus Incentive Plan. The fair value of time-vested stock options was estimated on the date of grant using the Black-Scholes option pricing model.

A summary of the status of the time-vested stock options as of March 31, 2024 (withno options granted, exercised, or forfeited since December 31, 2023) is presented below:

Share options outstanding at
(in thousands, except per share amounts)March 31,2024
KKI
Options2,993
Weighted Average Grant Date Fair Value$5.90
Weighted Average Exercise Price$14.30

The Company recorded total non-cash compensation expense related to the time-vested stock optionsof $0.9 million and $0.9 million for the quarters ended March 31, 2024 and April 2, 2023, respectively, which is included in Selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

The unrecognized compensation cost related to the unvested stock options and the weighted average period over which such cost is expected to be recognized are as follows:

As of March 31, 2024
Unrecognized Compensation CostRecognized Over aWeighted AveragePeriod of
KKI$7,3112.1 years

No time-vested stock options under the KKI plan vested during the fiscal periods presented.

Note 10 —Income Taxes

For interim tax reporting, the Company estimates a worldwide annual effective tax rate and applies that rate to the year-to-date ordinary (loss)/income. The tax effects of significant unusual or infrequently occurring items are excluded from the estimated annual effective tax rate calculation and recognized in the interim period in which they occur.

The Company’s effective income tax rates were -177.5% and 16.2% for the quarters ended March 31, 2024 and April 2, 2023, respectively. The Company’s effective income tax rate for the quarter ended March 31, 2024 differed from the respective statutory rates primarily due to disallowed executive compensation expense, the mix of income and taxes attributable to foreign jurisdictions, and noncontrolling interest in domestic joint ventures. The Company’s effective income tax rate for the quarter ended April 2, 2023 differed from the respective statutory rates primarily due to disallowed executive compensation expense, the mix of income and taxes attributable to foreign jurisdictions, and a discrete tax benefit unrelated to ongoing operations.

Note 11 —Commitments and Contingencies

Pending Litigation

In March 2023, an employee filed a lawsuit on behalf of himself and all others similarly situated against the Company, alleging violations of the Illinois Biometric Information Privacy Act. In May 2023, the Company moved for a stay pending resolution of a similar case before the Illinois Supreme Court. The Company believes that it has meritorious defenses to the complaint and will vigorously defend against these claims. The Company has accrued an immaterial amount and management does not believe that this matter will have a material adverse effect on the Company’s financial results.

Other Legal Matters

The Company also is engaged in various legal proceedings arising in the normal course of business. The Company maintains insurance policies against certain kinds of such claims and suits, including insurance policies for workers’ compensation and personal injury, all of which are subject to deductibles. While the ultimate outcome of these matters could differ from management’s expectations, management currently does not believe their resolution will have a material adverse effect on the Company’s Condensed Consolidated Financial Statements.

Other Commitments and Contingencies

The Company’s primary banks issued letters of credit on its behalf totaling $13.3 million and $15.4 million as of March 31, 2024 and December 31, 2023, respectively, a majority of which secure the Company’s reimbursement obligations to insurers under its self-insurance arrangements.

Note 12 —Related Party Transactions

The Company has an equity ownership inthree franchisees, KremeWorks USA, LLC (20% ownership), KremeWorks Canada, L.P. (25% ownership), and Krispy Kreme Doughnuts France SAS (“KK France”) (33% ownership), with an aggregate carrying value of $2.3 million and $2.8 million as of March 31, 2024 and December 31, 2023, respectively.

Note 13 —Revenue Recognition

Disaggregation of Revenues

Revenues are disaggregated as follows:

Quarter Ended
March 31, 2024April 2, 2023
Company Shops, DFD and Branded Sweet Treats$420,213$392,814
Mix and equipment revenue from franchisees13,29917,860
Franchise royalties and other9,1868,276
Total net revenues$442,698$418,950

Other revenues include advertising fund contributions from franchisees, rental income, development and franchise fees, and licensing royalties from customers for use of the Krispy Kreme brand, such as Keurig coffee cups.

Contract Balances

Deferred revenue and related receivables are as follows:

March 31, 2024December 31, 2023Balance Sheet Location
Trade receivables, net of allowances of $450 and $564, respectively$50,212$45,858Accounts receivables, net
Deferred revenue:
Current$21,772$22,066Accrued liabilities
Noncurrent7,7146,005Other long-term obligations and deferred credits
Total deferred revenue$29,486$28,071

Trade receivables relate primarily to payments due for royalties, franchise fees, advertising fees, sale of products, and licensing fees. Deferred revenue primarily represents the Company’s remaining performance obligations under gift cards and franchise and development agreements for which consideration has been received or is receivable and is generally recognized on a straight-line basis over the remaining term of the related agreement. The noncurrent portion of deferred revenue primarily relates to the remaining performance obligations in the franchise and development agreements.

Note 14 —Net Loss per Share

The following table presents the calculations of basic and diluted EPS:

Quarter Ended
(in thousands, except per share amounts)March 31, 2024April 2, 2023
Net loss attributable to Krispy Kreme, Inc.$(8,534)$(301)
Additional income attributed to noncontrolling interest due to subsidiary potential common shares(19)(10)
Net loss attributable to common shareholders - Diluted$(8,553)$(311)
Basic weighted average common shares outstanding168,685168,141
Dilutive effect of outstanding common stock options, RSUs, and PSUs——
Diluted weighted average common shares outstanding168,685168,141
Loss per share attributable to common shareholders:
Basic$(0.05)$0.00
Diluted$(0.05)$0.00

Potential dilutive shares consist of unvested RSUs and PSUs, calculated using the treasury stock method. The calculation of dilutive shares outstanding excludes certain unvested RSUs granted under certain subsidiaries’ executive ownership plans and long-term incentive plans, because their inclusion would have been antidilutive.

The following table summarizes the gross number of potential dilutive unvested RSUs and PSUs excluded due to antidilution (unadjusted for the treasury stock method):

Quarter Ended
(in thousands)March 31, 2024April 2, 2023
KKI6,6375,097
KK U.K.77
Insomnia Cookies——
KK Australia185276
KK Mexico——

For both quarters ended March 31, 2024 and April 2, 2023, all 3.0 million time-vested stock options were excluded from the computation of diluted weighted average common shares outstanding based on application of the treasury stock method.

Note 15 —Segment Reporting

The Company conducts business through thethree reportable segments: U.S., International, and Market Development. Unallocated corporate costs are excluded from the Company’s measurement of segment performance. These costs include general corporate expenses.

As discussed in Note 1, Description of Business and Summary of Significant Accounting Policies, effective January 1, 2024, the Company realigned its segment reporting structure such that the Company-owned Canada and Japan businesses have moved from the Market Development reportable operating segment to the International reportable operating segment. All segment information has been restated to be consistent with current presentation.

The reportable segment results are as follows:

Quarter Ended
March 31, 2024April 2, 2023
Net revenues:
U.S.$295,935$281,344
International124,750111,988
Market Development22,01325,618
Total net revenues$442,698$418,950
Quarter Ended
March 31, 2024April 2, 2023
Segment Adjusted EBITDA:
U.S.$42,616$38,535
International20,53618,982
Market Development11,90011,551
Corporate(16,864)(14,140)
Adjusted EBITDA58,18854,928
Interest expense, net13,73611,988
Income tax expense4,262317
Depreciation and amortization expense33,58627,939
Share-based compensation6,9865,545
Employer payroll taxes related to share-based compensation4325
Other non-operating expense, net (1)573999
Strategic initiatives (2)4,82113,469
Acquisition and integration expenses (3)24891
New market penetration expenses (4)46694
Shop closure expenses/(income), net (5)139(679)
Restructuring and severance expenses (6)6580
Gain on sale-leaseback—(9,661)
Other (7)(15)2,577
Net (loss)/income$(6,663)$1,644

(1)Primarily foreign translation gains and losses in each period.

(2)The quarter ended March 31, 2024 consists primarily of costs associated with global transformation, exploring strategic alternatives for the Insomnia Cookies business, and preparing for the McDonald’s U.S. expansion (with these specific initiatives aggregating to approximately $4.6 million of the total). The quarter ended April 2, 2023 consists primarily of costs associated with the decision to exit the Branded Sweet Treats business, including property, plant and equipment impairments, inventory write-offs, employee severance, and other related costs (approximately $13.4 million of the total).

(3)Consists of acquisition and integration-related costs in connection with the Company’s business and franchise acquisitions, including legal, due diligence, and advisory fees incurred in connection with acquisition and integration-related activities for the applicable period.

(4)Consists of start-up costs associated with entry into new countries for which the Company’s brands have not previously operated, including the Insomnia Cookies brand entering Canada and the U.K.

(5)Includes lease termination costs, impairment charges, and loss on disposal of property, plant and equipment. The quarter ended April 2, 2023 includes gains related to the termination of leases at certain Krispy Kreme shops in the U.S. where the Company had already recognized impairment of the corresponding right of use assets in a prior period.

(6)The quarter ended April 2, 2023 consists primarily of costs associated with restructuring of the global executive team.

(7)The quarters ended March 31, 2024 and April 2, 2023 consist primarily of legal and other regulatory expenses incurred outside the ordinary course of business. The regulatory expenses incurred in the quarter ended April 2, 2023 relate to previous business acquisitions.

Note 16 —Subsequent Events

The Company evaluated subsequent events and transactions for potential recognition or disclosure in the Condensed Consolidated Financial Statements through May 9, 2024, the date the Condensed Consolidated Financial Statements were available to be issued. All subsequent events requiring recognition and disclosure have been incorporated into these Condensed Consolidated Financial Statements.

On April 30, 2024, the Company’s Board of Directors declared a $0.035 per share cash dividend payable on August 7, 2024, to shareholders of record on July 24, 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.